Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
USD |
NASDAQ |
Mar 08, 16:00
Harpoon Therapeutics Enterprise Value: 460.74M for March 11, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Merck & Co., Inc. | 273.10B |
| Axonics Inc (DELISTED) | -- |
| Johnson & Johnson | 529.11B |
| Boston Scientific Corp. | 153.39B |
| Ambrx Biopharma Inc (DELISTED) | 1.542B |
Enterprise Value Related Metrics
| Profit Margin (Quarterly) | -40.51% |
| Earnings Yield | -38.07% |
| Normalized Earnings Yield | -36.51 |